Barinthus Biotherapeutics Plc. - ADR Live Stock Price Today, Share Analysis and Chart

Name: Barinthus Biotherapeutics Plc. - ADR: Is Infosys Ltd. worth buying?
Item: Barinthus Biotherapeutics Plc. - ADR
Rating: 2.12308325
Author: Trendlyne DVM scores

about

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment...

1.22 0.01 (0.83%)

58.22% Fall from 52W High

37,960

XNAS Volume

XNAS 26 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

26.8 / 100

Technically Neutral

58.1 / 100

1Yr Price target upside is 269%

2 analysts

Barinthus Biotherapeutics Plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Barinthus Biotherapeutics Plc. - ADR Live Stock Price Today, Share Analysis and Chart

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment...

58.22% Fall from 52W High

SWOT Analysis

Barinthus Biotherapeutics Plc Live Price Chart